Cabaletta Bio, Inc. (CABA) vs Century Therapeutics, Inc. (IPSC)

Cabaletta Bio, Inc. and Century Therapeutics, Inc. are both Biotechnology companies. Cabaletta Bio, Inc. and Century Therapeutics, Inc. are of similar size ($271.6M and $262.8M). Across the 10 metrics below, Century Therapeutics, Inc. leads on 7 and Cabaletta Bio, Inc. on 3.

Valuation

Metric CABA IPSC Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2.45 9.71
P/B 1.01 1.21 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.07 n/m 0.64
EV/Sales n/m 1.41 9.21
Earnings yield (111.35%) (67.88%) (33.15%)
Free cash flow yield (72.80%) (31.23%) (25.50%)

Profitability

Metric CABA IPSC Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (93.20%) (49.65%) (56.36%)
Return on assets (75.36%) (38.41%) (48.04%)
Return on invested capital 0.00% (64.92%) 0.00%

Growth

Metric CABA IPSC Biotechnology median
Revenue growth (TTM) — 8,286.72% 6.02%
EPS growth (last fiscal year) 10.26% 93.12% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CABA IPSC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.79 8.28 4.72
Net debt to EBITDA 0.84 17.95 0.96

Dividend

Metric CABA IPSC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CABA IPSC Biotechnology median
Market cap 262.79m 271.61m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack